vs
Side-by-side financial comparison of Federal Realty Investment Trust (FRT) and Pediatrix Medical Group, Inc. (MD). Click either name above to swap in a different company.
Pediatrix Medical Group, Inc. is the larger business by last-quarter revenue ($493.8M vs $336.0M, roughly 1.5× Federal Realty Investment Trust). Federal Realty Investment Trust runs the higher net margin — 38.6% vs 6.8%, a 31.8% gap on every dollar of revenue. On growth, Federal Realty Investment Trust posted the faster year-over-year revenue change (8.7% vs -1.7%). Over the past eight quarters, Federal Realty Investment Trust's revenue compounded faster (6.5% CAGR vs -0.1%).
Federal Realty Investment Trust is a real estate investment trust that invests in shopping centers in the Northeastern United States, the Mid-Atlantic states, California, and South Florida.
Pediatrix Medical Group, Inc. is a leading U.S. specialized medical service provider focusing on maternal-fetal care, neonatology, pediatric cardiology and other pediatric subspecialties. It partners with U.S. healthcare facilities to deliver evidence-based care to women, newborns and children.
FRT vs MD — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $336.0M | $493.8M |
| Net Profit | $129.7M | $33.7M |
| Gross Margin | — | — |
| Operating Margin | 53.8% | 9.9% |
| Net Margin | 38.6% | 6.8% |
| Revenue YoY | 8.7% | -1.7% |
| Net Profit YoY | 103.5% | 10.5% |
| EPS (diluted) | $1.49 | $0.40 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $336.0M | — | ||
| Q4 25 | $336.0M | $493.8M | ||
| Q3 25 | $322.3M | $492.9M | ||
| Q2 25 | $311.5M | $468.8M | ||
| Q1 25 | $309.2M | $458.4M | ||
| Q4 24 | $311.4M | $502.4M | ||
| Q3 24 | $303.6M | $511.2M | ||
| Q2 24 | $296.1M | $504.3M |
| Q1 26 | $129.7M | — | ||
| Q4 25 | $129.7M | $33.7M | ||
| Q3 25 | $61.6M | $71.7M | ||
| Q2 25 | $155.9M | $39.3M | ||
| Q1 25 | $63.8M | $20.7M | ||
| Q4 24 | $65.5M | $30.5M | ||
| Q3 24 | $61.0M | $19.4M | ||
| Q2 24 | $112.0M | $-153.0M |
| Q1 26 | 53.8% | — | ||
| Q4 25 | 53.8% | 9.9% | ||
| Q3 25 | 34.3% | 13.8% | ||
| Q2 25 | 65.1% | 12.8% | ||
| Q1 25 | 35.0% | 7.0% | ||
| Q4 24 | 35.1% | 7.8% | ||
| Q3 24 | 34.9% | 6.6% | ||
| Q2 24 | 53.0% | -31.3% |
| Q1 26 | 38.6% | — | ||
| Q4 25 | 38.6% | 6.8% | ||
| Q3 25 | 19.1% | 14.5% | ||
| Q2 25 | 50.0% | 8.4% | ||
| Q1 25 | 20.6% | 4.5% | ||
| Q4 24 | 21.0% | 6.1% | ||
| Q3 24 | 20.1% | 3.8% | ||
| Q2 24 | 37.8% | -30.3% |
| Q1 26 | $1.49 | — | ||
| Q4 25 | $1.49 | $0.40 | ||
| Q3 25 | $0.69 | $0.84 | ||
| Q2 25 | $1.78 | $0.46 | ||
| Q1 25 | $0.72 | $0.24 | ||
| Q4 24 | $0.74 | $0.37 | ||
| Q3 24 | $0.70 | $0.23 | ||
| Q2 24 | $1.32 | $-1.84 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $107.4M | $375.2M |
| Total DebtLower is stronger | $5.0B | $570.5M |
| Stockholders' EquityBook value | $3.2B | $865.9M |
| Total Assets | $9.1B | $2.2B |
| Debt / EquityLower = less leverage | 1.53× | 0.66× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $107.4M | — | ||
| Q4 25 | $107.4M | $375.2M | ||
| Q3 25 | $111.3M | $340.1M | ||
| Q2 25 | $177.0M | $224.7M | ||
| Q1 25 | $109.2M | $99.0M | ||
| Q4 24 | $123.4M | $229.9M | ||
| Q3 24 | $97.0M | $103.8M | ||
| Q2 24 | $103.2M | $19.4M |
| Q1 26 | $5.0B | — | ||
| Q4 25 | $5.0B | $570.5M | ||
| Q3 25 | — | $577.2M | ||
| Q2 25 | — | $583.9M | ||
| Q1 25 | — | $590.5M | ||
| Q4 24 | $4.5B | $597.1M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
| Q1 26 | $3.2B | — | ||
| Q4 25 | $3.2B | $865.9M | ||
| Q3 25 | $3.2B | $890.7M | ||
| Q2 25 | $3.2B | $833.8M | ||
| Q1 25 | $3.2B | $789.2M | ||
| Q4 24 | $3.2B | $764.9M | ||
| Q3 24 | $3.1B | $732.5M | ||
| Q2 24 | $3.0B | $706.5M |
| Q1 26 | $9.1B | — | ||
| Q4 25 | $9.1B | $2.2B | ||
| Q3 25 | $8.9B | $2.2B | ||
| Q2 25 | $8.6B | $2.1B | ||
| Q1 25 | $8.6B | $2.0B | ||
| Q4 24 | $8.5B | $2.2B | ||
| Q3 24 | $8.5B | $2.1B | ||
| Q2 24 | $8.4B | $2.0B |
| Q1 26 | 1.53× | — | ||
| Q4 25 | 1.53× | 0.66× | ||
| Q3 25 | — | 0.65× | ||
| Q2 25 | — | 0.70× | ||
| Q1 25 | — | 0.75× | ||
| Q4 24 | 1.42× | 0.78× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | $114.1M |
| Free Cash FlowOCF − Capex | — | — |
| FCF MarginFCF / Revenue | — | — |
| Capex IntensityCapex / Revenue | — | — |
| Cash ConversionOCF / Net Profit | — | 3.39× |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $622.4M | $114.1M | ||
| Q3 25 | $147.8M | $137.3M | ||
| Q2 25 | $150.7M | $137.2M | ||
| Q1 25 | $179.0M | $-117.5M | ||
| Q4 24 | $574.6M | $133.0M | ||
| Q3 24 | $144.1M | $91.8M | ||
| Q2 24 | $169.7M | $107.0M |
| Q1 26 | — | — | ||
| Q4 25 | 4.80× | 3.39× | ||
| Q3 25 | 2.40× | 1.91× | ||
| Q2 25 | 0.97× | 3.49× | ||
| Q1 25 | 2.81× | -5.66× | ||
| Q4 24 | 8.77× | 4.36× | ||
| Q3 24 | 2.36× | 4.72× | ||
| Q2 24 | 1.52× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
FRT
Segment breakdown not available.
MD
| Health Care Patient Service | $421.6M | 85% |
| Hospitals Contracts | $70.0M | 14% |
| Other | $2.2M | 0% |
